enVVeno Medical Ownership 2024 | Who Owns enVVeno Medical Now?

Overview RevenueFinancials Chart

Institutional Ownership

20.40%

Insider Ownership

0.38%

Retail Ownership

79.22%

Institutional Holders

28.00

enVVeno Medical Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
KINGDON CAPITAL MANAGEMENT, L.L.C.	4.07%	0.37%	653,870	-	-	3,432,818	Jun 30, 2024
PERCEPTIVE ADVISORS LLC	3.88%	0.08%	623,315	-	-	3,272,404	Jun 30, 2024
VANGUARD GROUP INC	3.67%	0.00%	589,141	15,186	2.65%	3,092,990	Jun 30, 2024
NANTAHALA CAPITAL MANAGEMENT, LLC	2.98%	0.15%	477,855	-17,881	-3.61%	2,508,739	Jun 30, 2024
UBS OCONNOR LLC	1.44%	0.08%	230,790	4,482	1.98%	1,211,648	Jun 30, 2024
ADAR1 CAPITAL MANAGEMENT, LLC	1.26%	0.20%	201,728	-	-	1,059,072	Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC	0.87%	0.00%	139,774	2,318	1.69%	733,935	Jun 30, 2024
MORGAN STANLEY	0.59%	-	94,873	-2,677	-2.74%	498,083	Jun 30, 2024
BLACKROCK INC.	0.25%	-	39,469	1,978	5.28%	207,213	Jun 30, 2024
WESTSIDE INVESTMENT MANAGEMENT, INC.	0.24%	0.05%	38,762	35,012	933.65%	203,505	Jun 30, 2024
NORTHERN TRUST CORP	0.21%	-	34,270	-872	-2.48%	179,917,000	Jun 30, 2024
LAIRD NORTON TRUST COMPANY, LLC	0.21%	0.02%	33,000	-	-	173,250	Jun 30, 2024
FERMATA ADVISORS, LLC	0.19%	0.04%	30,949	7,751	33.41%	162,482	Jun 30, 2024
STATE STREET CORP	0.17%	-	26,500	1,900	7.72%	139,125,000	Jun 30, 2024
UBS GROUP AG	0.10%	-	16,800	11,242	202.27%	88,200	Jun 30, 2024
DIMENSIONAL FUND ADVISORS LP	0.10%	-	16,411	-	-	86,158	Jun 30, 2024
ARTHUR M. COHEN & ASSOCIATES, LLC	0.09%	0.01%	14,000	14,000	100.00%	73,500	Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	0.01%	0.00%	2,388	-1,099	-31.52%	12,537	Jun 30, 2024
WELLS FARGO & COMPANY/MN	0.01%	-	2,000	-95	-4.53%	10,500	Jun 30, 2024
CIBC PRIVATE WEALTH GROUP, LLC	0.01%	-	860	-	-	4,283	Jun 30, 2024

enVVeno Medical's largest institutional shareholder is KINGDON CAPITAL MANAGEMENT, L.L.C., holding 4.07% of the company's total share outstanding, currently valued at $3.43M. The top 10 institutional shareholders own together 19.24% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
KINGDON CAPITAL MANAGEMENT, L.L.C.	4.07%	0.37%	653,870	-	-	3,432,818	Jun 30, 2024
ADAR1 CAPITAL MANAGEMENT, LLC	1.26%	0.20%	201,728	-	-	1,059,072	Jun 30, 2024
NANTAHALA CAPITAL MANAGEMENT, LLC	2.98%	0.15%	477,855	-17,881	-3.61%	2,508,739	Jun 30, 2024
PERCEPTIVE ADVISORS LLC	3.88%	0.08%	623,315	-	-	3,272,404	Jun 30, 2024
UBS OCONNOR LLC	1.44%	0.08%	230,790	4,482	1.98%	1,211,648	Jun 30, 2024
WESTSIDE INVESTMENT MANAGEMENT, INC.	0.24%	0.05%	38,762	35,012	933.65%	203,505	Jun 30, 2024
FERMATA ADVISORS, LLC	0.19%	0.04%	30,949	7,751	33.41%	162,482	Jun 30, 2024
LAIRD NORTON TRUST COMPANY, LLC	0.21%	0.02%	33,000	-	-	173,250	Jun 30, 2024
ARTHUR M. COHEN & ASSOCIATES, LLC	0.09%	0.01%	14,000	14,000	100.00%	73,500	Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	0.01%	0.00%	2,388	-1,099	-31.52%	12,537	Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC	0.87%	0.00%	139,774	2,318	1.69%	733,935	Jun 30, 2024
VANGUARD GROUP INC	3.67%	0.00%	589,141	15,186	2.65%	3,092,990	Jun 30, 2024
MORGAN STANLEY	0.59%	-	94,873	-2,677	-2.74%	498,083	Jun 30, 2024
NORTHERN TRUST CORP	0.21%	-	34,270	-872	-2.48%	179,917,000	Jun 30, 2024
DIMENSIONAL FUND ADVISORS LP	0.10%	-	16,411	-	-	86,158	Jun 30, 2024
UBS GROUP AG	0.10%	-	16,800	11,242	202.27%	88,200	Jun 30, 2024
CIBC PRIVATE WEALTH GROUP, LLC	0.01%	-	860	-	-	4,283	Jun 30, 2024
ADVISOR GROUP HOLDINGS, INC.	0.00%	-	600	-10,750	-94.71%	3,150	Jun 30, 2024
STATE STREET CORP	0.17%	-	26,500	1,900	7.72%	139,125,000	Jun 30, 2024
BLACKROCK INC.	0.25%	-	39,469	1,978	5.28%	207,213	Jun 30, 2024

The largest enVVeno Medical shareholder by % of total assets is KINGDON CAPITAL MANAGEMENT, L.L.C.. The company owns 653.87K shares of enVVeno Medical (NVNO), representing 0.37% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
WESTSIDE INVESTMENT MANAGEMENT, INC.	0.24%	0.05%	38,762	35,012	933.65%	203,505	Jun 30, 2024
VANGUARD GROUP INC	3.67%	0.00%	589,141	15,186	2.65%	3,092,990	Jun 30, 2024
ARTHUR M. COHEN & ASSOCIATES, LLC	0.09%	0.01%	14,000	14,000	100.00%	73,500	Jun 30, 2024
UBS GROUP AG	0.10%	-	16,800	11,242	202.27%	88,200	Jun 30, 2024
FERMATA ADVISORS, LLC	0.19%	0.04%	30,949	7,751	33.41%	162,482	Jun 30, 2024
UBS OCONNOR LLC	1.44%	0.08%	230,790	4,482	1.98%	1,211,648	Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC	0.87%	0.00%	139,774	2,318	1.69%	733,935	Jun 30, 2024
BLACKROCK INC.	0.25%	-	39,469	1,978	5.28%	207,213	Jun 30, 2024
STATE STREET CORP	0.17%	-	26,500	1,900	7.72%	139,125,000	Jun 30, 2024
SIMPLEX TRADING, LLC	0.00%	-	667	667	100.00%	3,000	Jun 30, 2024
ROYAL BANK OF CANADA	0.00%	-	115	115	100.00%	1,000	Jun 30, 2024
BANK OF AMERICA CORP /DE/	0.00%	-	99	99	100.00%	520	Jun 30, 2024
CIBC PRIVATE WEALTH GROUP, LLC	0.01%	-	860	-	-	4,283	Jun 30, 2024
DIMENSIONAL FUND ADVISORS LP	0.10%	-	16,411	-	-	86,158	Jun 30, 2024
LAIRD NORTON TRUST COMPANY, LLC	0.21%	0.02%	33,000	-	-	173,250	Jun 30, 2024
PERCEPTIVE ADVISORS LLC	3.88%	0.08%	623,315	-	-	3,272,404	Jun 30, 2024
ADAR1 CAPITAL MANAGEMENT, LLC	1.26%	0.20%	201,728	-	-	1,059,072	Jun 30, 2024
KINGDON CAPITAL MANAGEMENT, L.L.C.	4.07%	0.37%	653,870	-	-	3,432,818	Jun 30, 2024
WELLS FARGO & COMPANY/MN	0.01%	-	2,000	-95	-4.53%	10,500	Jun 30, 2024
NORTHERN TRUST CORP	0.21%	-	34,270	-872	-2.48%	179,917,000	Jun 30, 2024

As of Jun 30 2024, enVVeno Medical's largest institutional buyer is WESTSIDE INVESTMENT MANAGEMENT, INC.. The company purchased 35.01K stocks of NVNO, valued at $203.50K.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
VELAN CAPITAL INVESTMENT MANAGEMENT LP	-	-	-	-172,235	-100.00%	-	Jun 30, 2024
MARSHALL WACE, LLP	-	-	-	-40,120	-100.00%	-	Jun 30, 2024
JANNEY MONTGOMERY SCOTT LLC	-	-	-	-34,140	-100.00%	-	Jun 30, 2024
SQUAREPOINT OPS LLC	-	-	-	-22,402	-100.00%	-	Jun 30, 2024
QUADRATURE CAPITAL LTD	-	-	-	-18,872	-100.00%	-	Jun 30, 2024
NANTAHALA CAPITAL MANAGEMENT, LLC	2.98%	0.15%	477,855	-17,881	-3.61%	2,508,739	Jun 30, 2024
HRT FINANCIAL LP	-	-	-	-13,873	-100.00%	-	Jun 30, 2024
ADVISOR GROUP HOLDINGS, INC.	0.00%	-	600	-10,750	-94.71%	3,150	Jun 30, 2024
ACADIAN ASSET MANAGEMENT LLC	-	-	-	-6,825	-100.00%	-	Jun 30, 2024
MORGAN STANLEY	0.59%	-	94,873	-2,677	-2.74%	498,083	Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	0.01%	0.00%	2,388	-1,099	-31.52%	12,537	Jun 30, 2024
NORTHERN TRUST CORP	0.21%	-	34,270	-872	-2.48%	179,917,000	Jun 30, 2024
WELLS FARGO & COMPANY/MN	0.01%	-	2,000	-95	-4.53%	10,500	Jun 30, 2024
KINGDON CAPITAL MANAGEMENT, L.L.C.	4.07%	0.37%	653,870	-	-	3,432,818	Jun 30, 2024
ADAR1 CAPITAL MANAGEMENT, LLC	1.26%	0.20%	201,728	-	-	1,059,072	Jun 30, 2024
PERCEPTIVE ADVISORS LLC	3.88%	0.08%	623,315	-	-	3,272,404	Jun 30, 2024
LAIRD NORTON TRUST COMPANY, LLC	0.21%	0.02%	33,000	-	-	173,250	Jun 30, 2024
DIMENSIONAL FUND ADVISORS LP	0.10%	-	16,411	-	-	86,158	Jun 30, 2024
CIBC PRIVATE WEALTH GROUP, LLC	0.01%	-	860	-	-	4,283	Jun 30, 2024
BANK OF AMERICA CORP /DE/	0.00%	-	99	99	100.00%	520	Jun 30, 2024

As of Jun 30 2024, enVVeno Medical's biggest institutional seller is VELAN CAPITAL INVESTMENT MANAGEMENT LP. The company sold -0.17M shares of NVNO, valued at -.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
SIMPLEX TRADING, LLC	0.00%	-	667	667	100.00%	3,000	Jun 30, 2024

enVVeno Medical's largest new institutional shareholder by number of shares is SIMPLEX TRADING, LLC, purchased 667.00 shares, valued at $3.00K, as of undefined.

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
VELAN CAPITAL INVESTMENT MANAGEMENT LP	-	-	-	-172,235	-100.00%	-	Jun 30, 2024
MARSHALL WACE, LLP	-	-	-	-40,120	-100.00%	-	Jun 30, 2024
JANNEY MONTGOMERY SCOTT LLC	-	-	-	-34,140	-100.00%	-	Jun 30, 2024
SQUAREPOINT OPS LLC	-	-	-	-22,402	-100.00%	-	Jun 30, 2024
QUADRATURE CAPITAL LTD	-	-	-	-18,872	-100.00%	-	Jun 30, 2024
HRT FINANCIAL LP	-	-	-	-13,873	-100.00%	-	Jun 30, 2024
ACADIAN ASSET MANAGEMENT LLC	-	-	-	-6,825	-100.00%	-	Jun 30, 2024

enVVeno Medical's largest sold out institutional shareholder by shares sold is VELAN CAPITAL INVESTMENT MANAGEMENT LP, sold -0.17M shares, valued at -, as of undefined.

enVVeno Medical Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
VANGUARD INDEX FUNDS	0.00%	559,521	132,577	31.05%	Mar 31, 2024
FIDELITY CONCORD STREET TRUST	0.00%	125,206	41,125	48.91%	Feb 29, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS	0.00%	11,710	-	-	Mar 31, 2024
SCHWAB CAPITAL TRUST	0.00%	2,462	-	-	Jan 31, 2024
DFA INVESTMENT DIMENSIONS GROUP INC	0.00%	10,335	-	-	Jan 31, 2024
USAA MUTUAL FUNDS TRUST	0.00%	1,030	-	-	Jan 31, 2024
Blackstone Alternative Investment Funds	0.00%	200	-200	-50.00%	Mar 31, 2023
EQ ADVISORS TRUST	0.00%	1,644	-	-	Mar 31, 2024
iSHARES TRUST	0.00%	21,547	-650	-2.93%	Mar 31, 2024
LINCOLN VARIABLE INSURANCE PRODUCTS TRUST	0.00%	1,679	-	-	Mar 31, 2024

enVVeno Medical's largest mutual fund holder by % of total assets is "VANGUARD INDEX FUNDS", owning 559.52K shares, compromising 0.00% of its total assets.

enVVeno Medical Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
30 Jun, 24	28	-17.65%
31 Mar, 24	34	3.03%
31 Dec, 23	33	37.50%
30 Sep, 23	24	4.35%
30 Jun, 23	23	27.78%
31 Mar, 23	18	-28.00%
31 Dec, 22	25	8.70%
30 Sep, 22	23	4.55%
30 Jun, 22	22	-8.33%
31 Mar, 22	24	-7.69%
31 Dec, 21	26	2500.00%
30 Sep, 21	1	-

As of 30 Jun 24, 28 institutions are holding enVVeno Medical's shares, representing a decrease of -17.65% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
30 Jun, 24	3,275,381	-10.11%
31 Mar, 24	3,643,857	-14.24%
31 Dec, 23	4,248,731	119.95%
30 Sep, 23	1,931,716	1.50%
30 Jun, 23	1,903,096	5.01%
31 Mar, 23	1,812,227	-0.89%
31 Dec, 22	1,828,540	-16.34%
30 Sep, 22	2,185,720	1.86%
30 Jun, 22	2,145,905	1.41%
31 Mar, 22	2,116,025	1.68%
31 Dec, 21	2,080,975	16947.39%
30 Sep, 21	12,207	-

enVVeno Medical (NVNO) has 3.28M shares outstanding as of 30 Jun 24, down -10.11% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
30 Jun, 24	20.40%	2.32%
31 Mar, 24	29.62%	2.07%
31 Dec, 23	37.83%	12.79%
30 Sep, 23	17.20%	5.99%
30 Jun, 23	16.95%	6.51%
31 Mar, 23	16.14%	6.09%
31 Dec, 22	16.28%	4.30%
30 Sep, 22	19.46%	5.33%
30 Jun, 22	19.11%	5.38%
31 Mar, 22	18.84%	3.28%
31 Dec, 21	23.97%	135552.26%
30 Sep, 21	0.13%	-

As of 30 Jun 24, enVVeno Medical is held by 20.40% institutional shareholders, representing a 2.32% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
30 Jun, 24	12	-45.45%
31 Mar, 24	22	-
31 Dec, 23	22	83.33%
30 Sep, 23	12	50.00%
30 Jun, 23	8	14.29%
31 Mar, 23	7	-30.00%
31 Dec, 22	10	11.11%
30 Sep, 22	9	-
30 Jun, 22	9	12.50%
31 Mar, 22	8	-68.00%
31 Dec, 21	25	2400.00%
30 Sep, 21	1	-

12 institutional shareholders have increased their position in NVNO stock as of 30 Jun 24 compared to 22 in the previous quarter (a -45.45% decrease).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
30 Jun, 24	8	33.33%
31 Mar, 24	6	200.00%
31 Dec, 23	2	-50.00%
30 Sep, 23	4	-
30 Jun, 23	4	100.00%
31 Mar, 23	2	-66.67%
31 Dec, 22	6	100.00%
30 Sep, 22	3	-50.00%
30 Jun, 22	6	-14.29%
31 Mar, 22	7	-
31 Dec, 21	-	-
30 Sep, 21	-	-

8 institutional shareholders have reduced their position in NVNO stock as of 30 Jun 24 compared to 6 in the previous quarter (a 33.33% increase).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
30 Jun, 24	28	-17.65%	3,275,381	-10.11%	20.40%	2.32%	12	-45.45%	8	33.33%
31 Mar, 24	34	3.03%	3,643,857	-14.24%	29.62%	2.07%	22	-	6	200.00%
31 Dec, 23	33	37.50%	4,248,731	119.95%	37.83%	12.79%	22	83.33%	2	-50.00%
30 Sep, 23	24	4.35%	1,931,716	1.50%	17.20%	5.99%	12	50.00%	4	-
30 Jun, 23	23	27.78%	1,903,096	5.01%	16.95%	6.51%	8	14.29%	4	100.00%
31 Mar, 23	18	-28.00%	1,812,227	-0.89%	16.14%	6.09%	7	-30.00%	2	-66.67%
31 Dec, 22	25	8.70%	1,828,540	-16.34%	16.28%	4.30%	10	11.11%	6	100.00%
30 Sep, 22	23	4.55%	2,185,720	1.86%	19.46%	5.33%	9	-	3	-50.00%
30 Jun, 22	22	-8.33%	2,145,905	1.41%	19.11%	5.38%	9	12.50%	6	-14.29%
31 Mar, 22	24	-7.69%	2,116,025	1.68%	18.84%	3.28%	8	-68.00%	7	-
31 Dec, 21	26	2500.00%	2,080,975	16947.39%	23.97%	135552.26%	25	2400.00%	-	-
30 Sep, 21	1	-	12,207	-	0.13%	-	1	-	-	-

enVVeno Medical Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source
Mar 15, 2024	Alavi Hamed	officer	Chief Technology Officer	S-Sale	Sell	8,334	$6.22	$51.84K	-

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Mar 15, 2024	Alavi Hamed	officer	Chief Technology Officer	M-Exempt	Sell	8,334	$3.59	$29.92K	91,666
Mar 15, 2024	Alavi Hamed	officer	Chief Technology Officer	S-Sale	Sell	8,334	$6.22	$51.84K	-
Jan 31, 2023	Alavi Hamed	officer	Chief Technology Officer		Sell	125,925	$6.70	$843.70K	-
Jan 31, 2023	Alavi Hamed	officer	Chief Technology Officer		Sell	320,000	$8.20	$2.62M	-
Jan 31, 2023	Alavi Hamed	officer	Chief Technology Officer		Sell	8,000	$10.00	$80.00K	-
Jan 31, 2023	Alavi Hamed	officer	Chief Technology Officer		Sell	50,000	-	-	-

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Mar 15, 2024	Alavi Hamed	officer	Chief Technology Officer	M-Exempt	Sell	8,334	$3.59	$29.92K	91,666
Mar 15, 2024	Alavi Hamed	officer	Chief Technology Officer	M-Exempt	Buy	8,334	$3.59	$29.92K	8,334
Mar 15, 2024	Alavi Hamed	officer	Chief Technology Officer	S-Sale	Sell	8,334	$6.22	$51.84K	-
Dec 07, 2023	Glynn Craig	officer	Chief Financial Officer	A-Award	Buy	75,000	$3.59	$269.25K	75,000
Dec 07, 2023	Jenusaitis Matthew	director	-	A-Award	Buy	13,856	$3.59	$49.74K	13,856
Dec 07, 2023	Alavi Hamed	officer	Chief Technology Officer	A-Award	Buy	100,000	$3.59	$359.00K	100,000
Dec 07, 2023	Glickman Marc H.	officer	SVP & Chief Medical Officer	A-Award	Buy	100,000	$3.59	$359.00K	100,000
Dec 07, 2023	Gray Robert	director	-	A-Award	Buy	13,856	$3.59	$49.74K	13,856
Dec 07, 2023	Shrivastava Sanjay	director	-	A-Award	Buy	13,856	$3.59	$49.74K	13,856
Dec 07, 2023	Duhay Francis	director	-	A-Award	Buy	13,856	$3.59	$49.74K	13,856
Dec 07, 2023	BERMAN ROBERT ANDREW	director, officer	Chief Executive Officer	A-Award	Buy	300,000	$3.59	$1.08M	300,000
Jan 31, 2023	Alavi Hamed	officer	Chief Technology Officer		Sell	125,925	$6.70	$843.70K	-
Jan 31, 2023	Alavi Hamed	officer	Chief Technology Officer		Sell	320,000	$8.20	$2.62M	-
Jan 31, 2023	Alavi Hamed	officer	Chief Technology Officer		Sell	8,000	$10.00	$80.00K	-
Jan 31, 2023	Alavi Hamed	officer	Chief Technology Officer		Sell	50,000	-	-	-
Dec 02, 2022	Jenusaitis Matthew	director	-	A-Award	Buy	8,403	-	-	8,403
Dec 02, 2022	Shrivastava Sanjay	director	-	A-Award	Buy	8,403	-	-	8,403
Dec 02, 2022	Gray Robert	director	-	A-Award	Buy	8,403	-	-	8,403
Dec 02, 2022	Duhay Francis	director	-	A-Award	Buy	8,403	-	-	8,403
Sep 16, 2022	Gray Robert	director	-	M-Exempt	Buy	1,041	-	-	7,655

The last insider sell of enVVeno Medical's stock was made by Alavi Hamed on Mar 15 2024, selling 8,334 shares at $3.59 per share (valued at $29.92K).

enVVeno Medical Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q1 2024	1	2	50.00%
Q4 2023	8	-	-
Q1 2023	-	4	-
Q4 2022	4	-	-
Q3 2022	3	2	150.00%
Q2 2022	2	-	-
Q4 2021	17	1	1700.00%
Q3 2021	3	2	150.00%
Q2 2021	5	-	-
Q1 2021	8	-	-
Q3 2020	14	17	82.35%
Q2 2020	-	15	-
Q4 2019	-	-	-
Q3 2019	6	1	600.00%
Q2 2019	-	2	-
Q1 2019	4	1	400.00%
Q4 2018	11	-	-
Q3 2018	2	1	200.00%
Q2 2018	-	11	-

1 total buy trades, and 2 total sell trades (buy/sell ratio of 0.50%) were made by enVVeno Medical's insiders, as of Q1 2024.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q1 2024	-	1	-
Q4 2023	-	-	-
Q1 2023	-	-	-
Q4 2022	-	-	-
Q3 2022	1	-	-
Q2 2022	2	-	-
Q4 2021	4	-	-
Q3 2021	1	-	-
Q2 2021	5	-	-
Q1 2021	-	-	-
Q3 2020	-	15	-
Q2 2020	-	15	-
Q4 2019	-	-	-
Q3 2019	-	-	-
Q2 2019	-	1	-
Q1 2019	4	-	-
Q4 2018	-	-	-
Q3 2018	-	-	-
Q2 2018	-	-	-

As of Q1 2024, Insider owners conducted 0 open market buy trades and 1 open market sell trades of enVVeno Medical's stocks.

enVVeno Medical Peer Ownership

Ticker	Company
AIMD	Ainos, Inc.
TLIS	Talis Biomedical Corporation
OFIX	Orthofix Medical Inc.
LNSR	LENSAR, Inc.
SSKN	STRATA Skin Sciences, Inc.
LUNG	Pulmonx Corporation
IRIX	IRIDEX Corporation
SRDX	Surmodics, Inc.
LIVN	LivaNova PLC
KIDS	OrthoPediatrics Corp.
OSA	ProSomnus, Inc. Common Stock
AZYO	Elutia Inc.
SIEN	Sientra, Inc.
AXGN	AxoGen, Inc.
PETV	PetVivo Holdings, Inc.
TNON	Tenon Medical, Inc.
RXST	RxSight, Inc.

NVNO Ownership FAQ

Who Owns enVVeno Medical?

enVVeno Medical is owned by institutional shareholders (20.40%), insiders (0.38%), and public (79.22%). The largest institutional shareholder of enVVeno Medical is KINGDON CAPITAL MANAGEMENT, L.L.C. (4.07% of total shares) and the top mutual fund owner is VANGUARD INDEX FUNDS (0.00% of total shares).

Who are the major institutional shareholders of enVVeno Medical?

enVVeno Medical's major institutional shareholders are KINGDON CAPITAL MANAGEMENT, L.L.C., PERCEPTIVE ADVISORS LLC, VANGUARD GROUP INC, NANTAHALA CAPITAL MANAGEMENT, LLC, and UBS OCONNOR LLC. The top five shareholders own together 16.04% of the company's share outstanding.

How many enVVeno Medical shareholders are there?

As of Jun 2024, there are 28 institutional shareholders of enVVeno Medical.

What percentage of enVVeno Medical is owned by KINGDON CAPITAL MANAGEMENT, L.L.C?

KINGDON CAPITAL MANAGEMENT, L.L.C owns 653.87K shares of enVVeno Medical, representing 4.07% of the company's total shares outstanding, valued at $3.43M (as of Jun 2024).

What percentage of enVVeno Medical is owned by PERCEPTIVE ADVISORS LLC?

As of Jun 2024, PERCEPTIVE ADVISORS LLC holds 623.32K shares of enVVeno Medical (NVNO), compromising 3.88% of the company, valued at $3.27M.

What percentage of enVVeno Medical is owned by VANGUARD GROUP INC?

VANGUARD GROUP INC is the third largest holder of enVVeno Medical. The company owns 589.14K of the company's shares outstanding (worth $3.09M).